Lactulose Recommended Dose
For chronic constipation, start with 15 g (approximately 15-30 mL) daily and titrate to achieve 2-3 soft stools per day; for hepatic encephalopathy, initiate with 30-45 mL (20-30 g) every 1-2 hours until bowel movements occur, then maintain with 30-45 mL three to four times daily. 1, 2
Dosing for Chronic Idiopathic Constipation
Initial Dosing:
- Begin with 15 g daily (equivalent to 15-30 mL or 1-2 packets) as the recommended starting dose 1
- The FDA-approved initial range is 10-20 g (15-30 mL) daily 2
Dose Titration:
- Adjust based on symptom response and side effects to achieve the therapeutic goal 1
- May increase up to 40 g (60 mL) daily if inadequate response after several days 3, 4
- This represents the FDA-approved maximum dose for constipation 3
Target Goal:
Important Caveats:
- Bloating and flatulence are dose-dependent side effects that commonly limit tolerability, particularly at higher doses 1, 4
- Lactulose is the only osmotic agent studied in pregnancy, making it a preferred option in this population 1
- Ensure adequate hydration as with any osmotic laxative 1
Dosing for Hepatic Encephalopathy
Acute Hepatic Encephalopathy
Initial Aggressive Dosing:
- Administer 30-45 mL (20-30 g) every 1-2 hours orally until at least 2 soft bowel movements are produced daily 5, 2
- This hourly dosing induces the rapid laxation needed in the initial phase of therapy 2
- Continue this aggressive regimen until clinical improvement occurs 5
Maintenance Dosing:
- Once bowel movements are established, reduce to 30-45 mL (20-30 g) administered 3-4 times daily 5, 2
- Titrate to maintain 2-3 soft stools per day as the therapeutic target 5, 3
Timeline for Response:
- Improvement may occur within 24 hours but may not begin before 48 hours or even later 2
- Continuous long-term therapy is indicated to lessen severity and prevent recurrence 2
Rectal Administration for Severe Cases
When to Use:
- Reserved for patients in impending coma or coma stage when aspiration risk exists 2
- Also appropriate when endoscopic or intubation procedures interfere with oral administration 2
Preparation and Administration:
- Mix 300 mL of lactulose with 700 mL of water or physiologic saline 5, 2
- Administer as retention enema via rectal balloon catheter 2
- Retain for 30-60 minutes 2
- May repeat every 4-6 hours if needed 2
- Avoid cleansing enemas containing soap suds or other alkaline agents 2
Transition Strategy:
- Start oral lactulose before stopping rectal administration entirely 2
- Goal is reversal of coma stage to enable oral medication 2
Critical Safety Considerations
Overuse Complications:
- Excessive dosing can cause dehydration, hypernatremia, and severe perianal skin irritation 5, 3
- Paradoxically, overuse may precipitate hepatic encephalopathy rather than treat it 3, 4
- Aspiration risk increases with aggressive dosing in obtunded patients 3
Monitoring Requirements:
- Monitor for perianal skin breakdown with chronic use 3
- Watch for electrolyte disturbances, particularly hypernatremia 5, 3
- If no response after appropriate dosing, investigate precipitating factors (infection, GI bleeding, constipation, medications) rather than escalating lactulose indefinitely 3
Common Pitfall:
- It is a dangerous misconception that lack of effect from smaller doses is remedied by much larger doses 3
- The therapeutic target is 2-3 soft bowel movements daily, not arbitrary higher numbers 5, 3
Adjunctive Therapy for Hepatic Encephalopathy
Rifaximin:
- Effective as adjunct to lactulose with dosing of 400 mg three times daily or 550 mg twice daily 5, 4
- Combination therapy shows better recovery rates and shorter hospital stays compared to lactulose alone 4
- Consider adding rifaximin rather than escalating lactulose beyond therapeutic targets 3
Alternative Agents:
- Lactitol 67-100 g daily is an equivalent alternative if lactulose is not tolerated 4